J&J | JNJ - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
AbbVie USD 12.54B 474M 2026-03
Abbott USD 5.86B 675M 2026-03
Amgen USD 6.89B 415M 2025-12
AstraZeneca USD 12.61B 225M 2026-03
Baxter International USD 891M 314M 2026-03
Bayer EUR 6.94B 1.58B 2025-12
Becton, Dickinson and Co. USD 2.15B 257M 2026-03
Biogen USD 1.82B 169.5M 2026-03
Boston Scientific USD 3.61B 64M 2026-03
Bristol-Myers Squibb USD 8.41B 381M 2025-12
CONMED USD 183.45M 34.84M 2026-03
Cooper Companies USD 735.4M 40.2M 2026-03
Dexcom USD 750.3M 42.4M 2026-03
Edwards Lifesciences USD 1.29B 59.4M 2026-03
Eli Lilly USD 15.92B 1.33B 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
GlaxoSmithKline GBP 5.75B 429M 2026-03
Globus Medical USD 496.26M 39.69M 2026-03
Insulet USD 540.8M 27.8M 2026-03
Integra LifeSciences USD 213.21M 3.89M 2026-03
Intuitive Surgical USD 1.83B 73.8M 2026-03
J&J USD 17.24B 642M 2026-03
Medtronic USD 6.01B 595M 2026-03
Merck USD 10.85B 2.57B 2025-12
Merit Medical Systems USD 184.8M 10.56M 2026-03
Novartis USD 10.07B 184M 2026-03
Pfizer USD 11.04B 1.24B 2026-03
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
Stryker USD 3.81B 675M 2026-03
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12
Zoetis USD 1.62B 20M 2026-03